These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28700730)

  • 21. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
    Ferri S; Longhi MS; De Molo C; Lalanne C; Muratori P; Granito A; Hussain MJ; Ma Y; Lenzi M; Mieli-Vergani G; Bianchi FB; Vergani D; Muratori L
    Hepatology; 2010 Sep; 52(3):999-1007. PubMed ID: 20683931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive immunity in autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis.
    Lapierre P; Béland K; Martin C; Alvarez F; Alvarez F
    Hepatology; 2010 May; 51(5):1789-98. PubMed ID: 20232291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
    Li J; Wang FP; She WM; Yang CQ; Li L; Tu CT; Wang JY; Jiang W
    J Viral Hepat; 2014 Feb; 21(2):129-40. PubMed ID: 24383926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.
    Oikawa T; Takahashi H; Ishikawa T; Hokari A; Otsuki N; Azuma M; Zeniya M; Tajiri H
    Pathol Int; 2007 Aug; 57(8):485-92. PubMed ID: 17610472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis.
    Mele D; Bossi G; Maggiore G; Oliviero B; Mantovani S; Bonelli B; Mondelli MU; Varchetta S
    Clin Immunol; 2018 Mar; 188():31-37. PubMed ID: 29233784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
    Yu X; Guo R; Ming D; Su M; Lin C; Deng Y; Lin Z; Su Z
    J Gastroenterol Hepatol; 2014 May; 29(5):1065-72. PubMed ID: 24236690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.
    Shen C; Yan WZ; Zhao CY; Che HH; Liu XY; Liu ZZ; Wang YD; Wang W; Li M; Gao J
    J Microbiol Immunol Infect; 2015 Apr; 48(2):137-46. PubMed ID: 24388581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR2/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6/IL-12/IL-4/IL-25 expression.
    Chi G; Feng XX; Ru YX; Xiong T; Gao Y; Wang H; Luo ZL; Mo R; Guo F; He YP; Zhang GM; Tian DA; Feng ZH
    Mol Immunol; 2018 Jul; 99():171-181. PubMed ID: 29793131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis.
    Huang C; Shen Y; Shen M; Fan X; Men R; Ye T; Yang L
    Front Pharmacol; 2021; 12():726128. PubMed ID: 34531750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenectomy induces biochemical remission and regeneration in experimental murine autoimmune hepatitis.
    Dywicki J; Buitrago-Molina LE; Noyan F; Schlue J; Iordanidis K; Manns MP; Wedemeyer H; Jaeckel E; Hardtke-Wolenski M
    Eur J Med Res; 2022 Dec; 27(1):284. PubMed ID: 36496477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th17/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B.
    Liu B; Gao W; Zhang L; Wang J; Chen M; Peng M; Ren H; Hu P
    Int Immunopharmacol; 2017 May; 46():48-55. PubMed ID: 28259000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future perspective: immunomodulatory therapy for autoimmune hepatitis.
    Sebode M; Lohse AW
    Dig Dis; 2014; 32(5):502-6. PubMed ID: 25034282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis.
    Sakaki M; Hiroishi K; Baba T; Ito T; Hirayama Y; Saito K; Tonoike T; Kushima M; Imawari M
    Hepatol Res; 2008 Apr; 38(4):354-61. PubMed ID: 18021223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2.
    Holder BS; Grant CR; Liberal R; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
    J Autoimmun; 2014 Sep; 53():26-32. PubMed ID: 24566085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia.
    Whitington PF; Vos MB; Bass LM; Melin-Aldana H; Romero R; Roy CC; Alvarez F
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):74-80. PubMed ID: 23969541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B.
    Otano I; Suarez L; Dotor J; Gonzalez-Aparicio M; Crettaz J; Olagüe C; Vales A; Riezu JI; Larrea E; Borras F; Benito A; Hernandez-Alcoceba R; Menne S; Prieto J; González-Aseguinolaza G
    Hepatology; 2012 Aug; 56(2):474-83. PubMed ID: 22334260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
    Foureau DM; Walling TL; Maddukuri V; Anderson W; Culbreath K; Kleiner DE; Ahrens WA; Jacobs C; Watkins PB; Fontana RJ; Chalasani N; Talwalkar J; Lee WM; Stolz A; Serrano J; Bonkovsky HL
    Clin Exp Immunol; 2015 Apr; 180(1):40-51. PubMed ID: 25418487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis.
    Choi YS; Lee J; Lee HW; Chang DY; Sung PS; Jung MK; Park JY; Kim JK; Lee JI; Park H; Cheong JY; Suh KS; Kim HJ; Lee JS; Kim KA; Shin EC
    Gut; 2015 Aug; 64(8):1303-13. PubMed ID: 25007815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.